Antidepressant class, age, and the risk of deliberate self-harm: A propensity score matched cohort study of SSRI and SNRI users in the USA

CNS Drugs

Volumn 28, Issue 1, 2014, Pages 79-88

  Miller, Matthew ^a   Pate, V ^b   Swanson, S A ^a   Azrael, D ^a   White, A ^b   Sturmer T ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE MALEATE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADOLESCENT; ADULT; ARTICLE; AUTOMUTILATION; CHILD; COHORT ANALYSIS; CORRELATION ANALYSIS; DEPRESSION; DRUG CLASSIFICATION; DRUG USE; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRESCRIPTION; PRIORITY JOURNAL; PROPENSITY SCORE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCHOOL CHILD; SUICIDAL BEHAVIOR; SUICIDE; UNITED STATES;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; CHILD; COHORT STUDIES; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; RISK; RISK ASSESSMENT; SELF-INJURIOUS BEHAVIOR; SEROTONIN UPTAKE INHIBITORS; SUICIDE; UNITED STATES; YOUNG ADULT;

EID: 84893497566     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.1007/s40263-013-0120-8     Document Type: Article

References (35)

1. Andy Mosholder briefing document. Food and Drug Administration Psychopharmacologic Drugs Advisory Committee Web site. http://www.fda.gov/ohrms/ dockets/ac/04/transcripts/4006T1.pdf. Accessed 11 Nov 12.
2. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63(3):332-9.
3. Stone M, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339:b2880.
4. Baldassano CF, et al. Akathisia: a review and case report following paroxetine treatment. Compr Psychiatry. 1996;37(2):122-4.
5. Hansen L, Wilkinson DG. Drug induced akathisia, suicidal ideation and its treatment in the elderly. Int J Geriatr Psychiatry. 2001;16(2):231-3.
6. Healy D, Whitaker C. Antidepressants and suicide: risk-benefit conundrums. J Psychiatry Neurosci. 2003;28(5):331-7.
7. Kasantikul D. Drug-induced akathisia and suicidal tendencies in psychotic patients. J Med Assoc Thai. 1998;81(7):551-4.
8. Lipinski JF Jr, et al. Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry. 1989;50(9):339-42.
9. Power AC, Cowen PJ. Fluoxetine and suicidal behaviour. Some clinical and theoretical aspects of a controversy. Br J Psychiatry. 1992;161:735-41.
10. Teicher MH, Glod CA, Cole JO. Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf. 1993;8(3):186-212.
11. Hamilton MS, Opler LA. Akathisia, suicidality, and fluoxetine. J Clin Psychiatry. 1992;53(11):401-6.
12. Pfeiffer PN, et al. Comorbid anxiety as a suicide risk factor among depressed veterans. Depress Anxiety. 2009;26(8):752-7.
13. Wojnar M, et al. Sleep problems and suicidality in the National Comorbidity Survey replication. J Psychiatr Res. 2009;43(5):526-31.
14. Smith EG. Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: confirmatory analysis and research implications. J Affect Disord. 2009;114(1-3):143-8.
15. Weiss JJ, Gorman JM. Antidepressant adherence and suicide risk in depressed youth. Am J Psychiatry. 2005;162(9):1756-7.
16. Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA. 2004;292(3):338-43.
17. Martinez C, et al. Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ. 2010;340:c249.
18. Martinez C, et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ. 2005;330(7488):389.
19. Rubino A, et al. Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. BMJ. 2007;334(7587):242.
20. Schneeweiss S, et al. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Pediatrics. 2010;125(5):876-88.
21. Schneeweiss S, et al. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data. Arch Gen Psychiatry. 2010;67(5):497-506.
22. Valenstein M, et al. Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment. J Clin Psychopharmacol. 2012;32(3):346-53.
23. Valuck RJ, et al. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study. CNS Drugs. 2004;18(15):1119-32.
24. Juurlink DN, et al. The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am J Psychiatry. 2006;163(5):813-21.
25. Cipriani A, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373(9665):746-58.
26. Cipriani A, et al. Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. Can J Psychiatry. 2007;52(9):553-62.
27. Freiman JA, et al. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med. 1978;299(13):690-4.
28. Parsons L (2001) Reducing bias in a propensity score matched-pair sample using greedy matching techniques. http://www2.sas.com/proceedings/sugi26/p214- 26.pdf. Accessed 1 Oct 2012.
29. Mosholder AD, Willy M. Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis. J Child Adolesc Psychopharmacol. 2006;16(1-2):25-32.
30. Dubicka B, Hadley S, Roberts C. Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Br J Psychiatry. 2006;189:393-8.
31. Hetrick S et al. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2007;(3):CD004851.
32. Piper JM, Ray WA, Griffin MR. Effects of Medicaid eligibility expansion on prenatal care and pregnancy outcome in Tennessee. JAMA. 1990;264(17):2219-23.
33. Strom BL, Carson JL. Use of automated databases for pharmacoepidemiology research. Epidemiol Rev. 1990;12:87-107.
34. West SL, et al. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol. 1995;142(10):1103-12.
35. Suissa S. Immeasurable time bias in observational studies of drug effects on mortality. Am J Epidemiol. 2008;168(3):329-35.